Diabetes from humans to cats

General and Comparative Endocrinology

Volumn 182, Issue , 2013, Pages 48-53

  Osto, M ^a   Zini, E ^a   Reusch, C E ^a   Lutz, T A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Feline diabetes; Glucotoxicity; Inflammation; Pancreas; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AMYLOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CASTRATION; CAT DISEASE; CLINICAL FEATURE; CYTOKINE RELEASE; DIABETOGENESIS; DISORDERS OF CARBOHYDRATE METABOLISM; FELINE DIABETES; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLUCOTOXICITY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SHORT SURVEY; SPECIES COMPARISON;

EID: 84871998429     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2012.11.019     Document Type: Short Survey

References (75)

1. Appleton D.J., Rand J.S., Sunvold G.D. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. Journal of Feline Medicine and Surgery 2001, 3:211-228.
2. Appleton D.J., Rand J.S., Sunvold G.D. Plasma leptin concentrations are independently associated with insulin sensitivity in lean and overweight cats. Journal of Feline Medicine and Surgery 2002, 4:83-93.
3. Biourge V., Nelson R.W., Feldman E.C., Willits N.H., Morris J.G., Rogers Q.R. Effect of weight gain and subsequent weight loss on glucose tolerance and insulin response in healthy cats. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 1997, 11:86-91.
4. Brennan C.L., Hoenig M., Ferguson D.C. GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domestic Animal Endocrinology 2004, 26:291-301.
5. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
6. Y. Forcada, A. Holder, R. Jepson, D. Church, B. Catchpole, A Missense Mutation in the Coding Sequence of MC4R (MC4R:c.92 C>T) is Associated with Diabetes Mellitus in DSH Cats. Proceedings, European College of Veterinary Internal Medicine - Companion Animals, Toulouse, France, 2010.
7. Cave N.J., Backus R.C., Marks S.L., Klasing K.C. Oestradiol, but not genistein, inhibits the rise in food intake following gonadectomy in cats, but genistein is associated with an increase in lean body mass. Journal of Animal Physiology and Animal Nutrition 2007, 91:400-410.
8. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450.
9. Colliard L., Paragon B.M., Lemuet B., Benet J.J., Blanchard G. Prevalence and risk factors of obesity in an urban population of healthy cats. Journal of Feline Medicine and Surgery 2009, 11:135-140.
10. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
11. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (New York, NY) 2007, 316:1331-1336. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research.
12. Dinarello C.A., Donath M.Y., Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity 2010, 17:314-321.
13. Donath M.Y., Boni-Schnetzler M., Ellingsgaard H., Halban P.A., Ehses J.A. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends in Endocrinology and Metabolism 2010, 21:261-267.
14. Donath M.Y., Ehses J.A., Maedler K., Schumann D.M., Ellingsgaard H., Eppler E., et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005, 54(Suppl. 2):S108-S113.
15. Ebstein W. Zur Therapie des Diabetes mellitus, insbesondere über die Anwendung des salicylsauren Natron bei demselben. Berliner Klinische Wochenschrift 1876, 13:337-340.
16. Ehses J.A., Perren A., Eppler E., Ribaux P., Pospisilik J.A., Maor-Cahn R., et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007, 56:2356-2370.
17. Ellingsgaard H., Ehses J.A., Hammar E.B., Van Lommel L., Quintens R., Martens G., et al. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13163-13168.
18. Ellingsgaard H., Hauselmann I., Schuler B., Habib A.M., Baggio L.L., Meier D.T., et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nature Medicine 2011, 17:1481-1489.
19. Geary N., Trace D., McEwen B., Smith G.P. Cyclic estradiol replacement increases the satiety effect of CCK-8 in ovariectomized rats. Physiology & Behavior 1994, 56:281-289.
20. Goh T.T., Mason T.M., Gupta N., So A., Lam T.K., Lam L., et al. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure. American Journal of Physiology 2007, 292:E549-E560.
21. Harris R.B. Leptin - much more than a satiety signal. Annual Review of Nutrition 2000, 20:45-75.
22. Henson M.S., O'Brien T.D. Feline models of type 2 diabetes mellitus. ILAR Journal/National Research Council, Institute of Laboratory Animal Resources 2006, 47:234-242.
23. Hoenig M., McGoldrick J.B., deBeer M., Demacker P.N., Ferguson D.C. Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats. Domestic Animal Endocrinology 2006, 30:333-344.
24. Hoenig M., Thomaseth K., Brandao J., Waldron M., Ferguson D.C. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domestic Animal Endocrinology 2006, 31:373-389.
25. Hoenig M., Thomaseth K., Waldron M., Ferguson D.C. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. American Journal of Physiology 2007, 292:R227-R234.
26. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
27. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nature Reviews Immunology 2008, 8:923-934.
28. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (New York, NY) 1993, 259:87-91.
29. Ishioka K., Omachi A., Sasaki N., Kimura K., Saito M. Feline adiponectin: molecular structures and plasma concentrations in obese cats. The Journal of Veterinary Medical Science/The Japanese Society of Veterinary Science 2009, 71:189-194.
30. Kanchuk M.L., Backus R.C., Calvert C.C., Morris J.G., Rogers Q.R. Weight gain in gonadectomized normal and lipoprotein lipase-deficient male domestic cats results from increased food intake and not decreased energy expenditure. The Journal of Nutrition 2003, 133:1866-1874.
31. Kaser S., Tatarczyk T., Stadlmayr A., Ciardi C., Ress C., Tschoner A., et al. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. European Journal of Clinical Investigation 2008, 38:827-834.
32. Khemtemourian L., Killian J.A., Hoppener J.W., Engel M.F. Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus. Experimental Diabetes Research 2008, 2008:421287.
33. Lorenzo A., Razzaboni B., Weir G.C., Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994, 368:756-760.
34. Lusby A.L., Kirk C.A., Bartges J.W. The role of key adipokines in obesity and insulin resistance in cats. Journal of the American Veterinary Medical Association 2009, 235:518-522.
35. Lutz T.A., Rand J.S. Pathogenesis of feline diabetes mellitus. The Veterinary Clinics of North America 1995, 25:527-552.
36. Lutz T.A., Rand J.S. Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques. Journal of Comparative Pathology 1997, 116:157-170.
37. Lutz T.A., Rand J.S., Watt P., Galloway A. Pancreatic biopsy in normal cats. Australian Veterinary Journal 1994, 71:223-225.
38. Ma Z., Westermark G.T., Johnson K.H., O'Brien T.D., Westermark P. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose, tolerant and diabetic cats. Amyloid: The International Journal of Experimental and Clinical Investigation 1998, 5:255-261.
39. Maedler K., Fontana A., Ris F., Sergeev P., Toso C., Oberholzer J., et al. FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8236-8241.
40. Maedler K., Oberholzer J., Bucher P., Spinas G.A., Donath M.Y. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003, 52:726-733.
41. Maedler K., Schulthess F.T., Bielman C., Berney T., Bonny C., Prentki M., et al. Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. The FASEB Journal 2008, 22:1905-1913.
42. Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H.I., Spinas G.A., et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. The Journal of Clinical Investigation 2002, 110:851-860.
43. Maedler K., Spinas G.A., Dyntar D., Moritz W., Kaiser N., Donath M.Y. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 2001, 50:69-76.
44. Maedler K., Spinas G.A., Lehmann R., Sergeev P., Weber M., Fontana A., et al. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 2001, 50:1683-1690.
45. Martin L.J., Siliart B., Dumon H.J., Nguyen P. Spontaneous hormonal variations in male cats following gonadectomy. Journal of Feline Medicine and Surgery 2006, 8:309-314.
46. Masters S.L., Dunne A., Subramanian S.L., Hull R.L., Tannahill G.M., Sharp F.A., et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nature Immunology 2010, 11:897-904.
47. McLaughlin T., Deng A., Yee G., Lamendola C., Reaven G., Tsao P.S., et al. Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 2010, 53:369-377.
48. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Yee G., Lamendola C., et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007, 50:1707-1715.
49. Miller C., Bartges J., Cornelius L., Norton N., Barton M. Tumor necrosis factor-alpha levels in adipose tissue of lean and obese cats. The Journal of Nutrition 1998, 128:2751S-2752S.
50. Mirzabekov T.A., Lin M.C., Kagan B.L. Pore formation by the cytotoxic islet amyloid peptide amylin. The Journal of Biological Chemistry 1996, 271:1988-1992.
51. Mori A., Lee P., Takemitsu H., Iwasaki E., Kimura N., Yagishita M., et al. Decreased gene expression of insulin signaling genes in insulin sensitive tissues of obese cats. Veterinary Research Communications 2009, 33:315-329.
52. Muranaka S., Mori N., Hatano Y., Saito T.R., Lee P., Kojima M., et al. Obesity induced changes to plasma adiponectin concentration and cholesterol lipoprotein composition profile in cats. Research in Veterinary Science 2010, 91:358-361.
53. Nelson R.W., Griffey S.M., Feldman E.C., Ford S.L. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 1999, 13:28-35.
54. Osto M., Zini E., Franchini M., Wolfrum C., Guscetti F., Hafner M., et al. Subacute endotoxemia induces adipose inflammation and changes in lipid and lipoprotein metabolism in cats. Endocrinology 2011, 152:804-815.
55. Paolisso G., Gambardella A., Amato L., Tortoriello R., D'Amore A., Varricchio M., et al. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995, 38:1295-1299.
56. Paris M., Bernard-Kargar C., Berthault M.F., Bouwens L., Ktorza A. Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. Endocrinology 2003, 144:2717-2727.
57. Radin M.J., Sharkey L.C., Holycross B.J. Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. Veterinary Clinical Pathology/American Society for Veterinary Clinical Pathology 2009, 38:136-156.
58. Rand J. Current understanding of feline diabetes: part 1, pathogenesis. Journal of Feline Medicine and Surgery 1999, 1:143-153.
59. Rand J.S., Fleeman L.M., Farrow H.A., Appleton D.J., Lederer R. Canine and feline diabetes mellitus: nature or nurture?. The Journal of Nutrition 2004, 134:2072S-2080S.
60. Russell K., Sabin R., Holt S., Bradley R., Harper E.J. Influence of feeding regimen on body condition in the cat. The Journal of Small Animal Practice 2000, 41:12-17.
61. Scarlett J.M., Donoghue S., Saidla J., Wills J. Overweight cats: prevalence and risk factors. International Journal of Obesity and Related Metabolic Disorders 1994, 18(Suppl. 1):S22-S28.
62. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of Clinical Investigation 2006, 116:3015-3025.
63. Shoelson S.E., Goldfine A.B. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nature Medicine 2009, 15:373-374.
64. Spellman C.W. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction. The Journal of the American Osteopathic Association 2010, 110:S2-7.
65. Stefan N., Wahl H.G., Fritsche A., Haring H., Stumvoll M. Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Hormone and Metabolic Research 2001, 33:432-438.
66. Thibault C., Guettet C., Laury M.C., N'Guyen J.M., Tormo M.A., Bailbe D., et al. In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period. Diabetologia 1993, 36:589-595.
67. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. The Journal of Clinical Investigation 2005, 115:1111-1119.
68. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes, Obesity & Metabolism 2006, 8:264-280.
69. Williamson R. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. British Medical Journal 1901, 1:760-762.
70. Yano B.L., Hayden D.W., Johnson K.H. Feline insular amyloid: incidence in adult cats with no clinicopathologic evidence of overt diabetes mellitus. Veterinary Pathology 1981, 18:310-315.
71. E. Zini, R. Zanetti, L. Coppola, M. Ackermann, T.A. Lutz, C.E. Reusch, L. Cavicchioli, Histological investigation of endocrine and exocrine pancreas in cats with diabetes mellitus. Proceedings, European College of Veterinary Internal Medicine - Companion Animals (Maastricht, September 6-8, 2011), Maastricht Exhibition and Congress Centre (MECC) in Maastricht, 2012.
72. Zini E., Hafner M., Osto M., Franchini M., Ackermann M., Lutz T.A., et al. Predictors of clinical remission in cats with diabetes mellitus. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 2010, 24:1314-1321.
73. Zini E., Linscheid P., Franchini M., Kaufmann K., Monnais E., Kutter A.P., et al. Partial sequencing and expression of genes involved in glucose metabolism in adipose tissues and skeletal muscle of healthy cats. The Veterinary Journal 2009, 180:66-70.
74. Zini E., Osto M., Franchini M., Guscetti F., Donath M.Y., Perren A., et al. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 2009, 52:336-346.
75. Zoran D.L. Obesity in dogs and cats: a metabolic and endocrine disorder. The Veterinary Clinics of North America 2010, 40:221-239.